Skip to main content

Abstract

Since 2002, when the first case of autoimmune pancreatitis (AIP) was recognized in Korea, more than 200 cases have been registered in Korea. This chapter reviews the cardinal features of Korean AIP patients in accordance with findings on imaging, serology, other organ involvement, histology, and response to steroids. Most of the Korean patients with AIP were older than 50 years of age and had diffuse pancreatic enlargement on imaging and increased serum IgG4 levels. Most commonly involved extrapancreatic organs were bile duct, kidney, and retroperitoneum. Histopathologically, idiopathic duct-centric chronic pancreatitis (type 2 AIP) was diagnosed in 12 % of Korean AIP patients. Clinical and radiological remission was achieved in all patients who were treated with corticosteroids. However, 30 % of the patients experienced a disease relapse after a follow-up of more than 2 years. This chapter also provides Korean strategy for evaluation and management of AIP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kim JY, Chang HS, Kim MH, et al. A case of autoimmune chronic pancreatitis improved with oral steroid therapy. Korean J Gastroenterol. 2002;39:304–8.

    Google Scholar 

  2. Kim KP, Kim MH, Lee SS, Seo DW, Lee SK. Autoimmune pancreatitis: it may be a worldwide entity. Gastroenterology. 2004;126(4):1214.

    Article  PubMed  Google Scholar 

  3. Ryu JK, Chung JB, Park SW, et al. Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas. 2008;37(4):377–85.

    Article  PubMed  Google Scholar 

  4. Park SJ, Kim MH, Moon SH, et al. Clinical characteristics, recurrence features, and treatment outcomes of 55 patients with autoimmune pancreatitis. Korean J Gastroenterol. 2008;52(4):230–46.

    PubMed  Google Scholar 

  5. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol. 2004;99(8):1605–16.

    Article  PubMed  Google Scholar 

  6. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol. 2006;12(16):2487–96.

    PubMed  Google Scholar 

  7. Kwon S, Kim MH, Choi EK. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas. 2007;34(3):279–86.

    Article  PubMed  Google Scholar 

  8. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43(6):403–8.

    Article  PubMed  CAS  Google Scholar 

  9. Park do H, Kim MH. Intrapancreatic common bile duct involvement of autoimmune pancreatitis: is it really IgG4-associated cholangitis? Gastroenterology. 2008;135(1):324–5. author reply 325.

    Article  PubMed  Google Scholar 

  10. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134(2):440–6.

    Article  PubMed  Google Scholar 

  11. Kim MH, Moon SH. The need for a consensus on the definition of remission of autoimmune pancreatitis after steroid treatment. Gut. 2010;59(12):1730.

    Article  PubMed  Google Scholar 

  12. Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut. 2008;57(12):1704–12.

    Article  PubMed  CAS  Google Scholar 

  13. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7(10):1097–103.

    Article  PubMed  CAS  Google Scholar 

  14. Kamisawa T, Imai M, Yui Chen P, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas. 2008;37(3):e62–7.

    Article  PubMed  Google Scholar 

  15. Sugumar A, Chari ST. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol. 2009;7(11 Suppl):S59–62.

    Article  PubMed  Google Scholar 

  16. Lee TY, Kim MH, Park do H, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol. 2009;193(2):343–8.

    Article  PubMed  Google Scholar 

  17. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41(7):626–31.

    Article  PubMed  Google Scholar 

  18. Okazaki K, Kawa S, Kamisawa T, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45(3):249–65.

    Article  PubMed  Google Scholar 

  19. Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc. 2008;68(2):358–61.

    Article  PubMed  Google Scholar 

  20. Kawakami H, Zen Y, Kuwatani M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25(10):1648–55.

    Article  PubMed  Google Scholar 

  21. Moon SH, Kim MH, Park do H, et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc. 2010;71(6):960–6.

    Article  PubMed  Google Scholar 

  22. Gardner TB, Levy MJ, Takahashi N, Smyrk TC, Chari ST. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol. 2009;104(7):1620–3.

    Article  PubMed  Google Scholar 

  23. Klapman JB, Chang KJ, Lee JG, Nguyen P. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol. 2005;100(12):2658–61.

    Article  PubMed  Google Scholar 

  24. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med. 2006;355(25):2670–6.

    Article  PubMed  CAS  Google Scholar 

  25. Levy P, Hammel P, Ruszniewski P. Diagnostic challenge in autoimmune pancreatitis: beware of shipwreck! Gut. 2008;57(12):1646–7.

    Article  PubMed  Google Scholar 

  26. Levy MJ, Reddy RP, Wiersema MJ, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc. 2005;61(3):467–72.

    Article  PubMed  Google Scholar 

  27. Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44(7):742–50.

    Article  PubMed  CAS  Google Scholar 

  28. Bang SJ, Kim MH, Kim do H, et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas. 2008;36(1):84–9.

    Article  PubMed  Google Scholar 

  29. Sreenarasimhaiah J. Efficacy of endoscopic ultrasound in characterizing mass lesions in chronic pancreatitis. J Clin Gastroenterol. 2008;42(1):81–5.

    Article  PubMed  Google Scholar 

  30. Song TJ, Kim MH, Moon SH, et al. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Am J Gastroenterol. 2010;105(7):1655–60.

    Article  PubMed  CAS  Google Scholar 

  31. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102(8):1646–53.

    Article  PubMed  CAS  Google Scholar 

  32. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut. 2007;56(12):1650–2.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Myung-Hwan Kim M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kim, MH., Moon, SH. (2013). Korean Experience. In: Levy, M., Chari, S. (eds) Autoimmune (IgG4-related) Pancreatitis and Cholangitis. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6430-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6430-4_23

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-6429-8

  • Online ISBN: 978-1-4419-6430-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics